81 FR 56658 - National Mammography Quality Assurance Advisory Committee; Amendment of Notice
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration Federal Register Volume 81, Issue 162 (August 22, 2016)
Food and Drug Administration
Federal Register Volume 81, Issue 162 (August 22, 2016)
| Page Range | 56658-56658 | |
| FR Document | 2016-19957 |
[Federal Register Volume 81, Number 162 (Monday, August 22, 2016)] [Notices] [Page 56658] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-19957] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-0001] National Mammography Quality Assurance Advisory Committee; Amendment of Notice AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the National Mammography Quality Assurance Advisory Committee. This meeting was announced in the Federal Register of August 5, 2016. The amendment is being made to reflect a change in the ADDRESSES portion of the document. There are no other changes. FOR FURTHER INFORMATION CONTACT: S.J. Anderson, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1552, Silver Spring, MD 20993-0002, [email protected], 301-796-6875, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code MA. Please call the Information Line for up-to-date information on this meeting. SUPPLEMENTARY INFORMATION: In the Federal Register of August 5, 2016 (81 FR 51918), FDA announced that a meeting of the National Mammography Quality Assurance Advisory Committee would be held on September 15, 2016. On page 51919, in the first column, in the ADDRESSES portion: Hilton Washington, DC/North, Salons A, B, C and D, 620 Perry Pkwy., Gaithersburg, MD 20877. The hotel's telephone number is 301-977-8900, is changed to read as follows: Gaithersburg Holiday Inn--Grand Ballroom, 2 Montgomery Village Ave., Gaithersburg, MD 20878. The hotel's telephone number is 301-948-8900. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees. Dated: August 17, 2016. Janice M. Soreth, Acting Associate Commissioner, Special Medical Programs. [FR Doc. 2016-19957 Filed 8-19-16; 8:45 am] BILLING CODE 4164-01-P
![56658 Federal Register / Vol. 81, No. 162 / Monday, August 22, 2016 / Notices
and will select and notify participants DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
by September 14, 2016. All requests to HUMAN SERVICES HUMAN SERVICES
make oral presentations must be
received by September 13, 2016. If Food and Drug Administration Food and Drug Administration
selected for presentation, any [Docket No. FDA–2016–N–2474]
presentation materials must be emailed [Docket No. FDA–2016–N–0001]
to David Litwack (see FOR FURTHER Agency Information Collection
INFORMATION CONTACT) no later than National Mammography Quality Activities; Proposed Collection;
September 16, 2016, at 5 p.m. No Assurance Advisory Committee; Comment Request; Reporting
commercial or promotional material Amendment of Notice Associated With Designated New
will be permitted to be presented or Animal Drugs for Minor Use and Minor
distributed at the public workshop. AGENCY: Food and Drug Administration, Species
HHS.
FDA is holding this public workshop AGENCY: Food and Drug Administration,
to obtain feedback on its recently ACTION: Notice. HHS.
released draft guidance documents: ACTION: Notice.
‘‘Use of Public Human Genetic Variant SUMMARY: The Food and Drug
Databases to Support Clinical Validity Administration (FDA) is announcing an SUMMARY: The Food and Drug
for Next Generation Sequencing-Based amendment to the notice of meeting of Administration (FDA) is announcing an
In Vitro Diagnostics’’ and ‘‘Use of the National Mammography Quality opportunity for public comment on the
Standards in the Food and Drug Assurance Advisory Committee. This proposed collection of certain
Administration’s Regulatory Oversight meeting was announced in the Federal information by the Agency. Under the
of Next Generation Sequencing-Based In Register of August 5, 2016. The Paperwork Reduction Act of 1995 (the
amendment is being made to reflect a PRA), Federal Agencies are required to
Vitro Diagnostics Used for Diagnosing
change in the ADDRESSES portion of the publish notice in the Federal Register
Germline Diseases’’. In order to permit
document. There are no other changes. concerning each proposed collection of
the widest possible opportunity to
information, including each proposed
obtain public comment, FDA is FOR FURTHER INFORMATION CONTACT: S.J. extension of an existing collection of
soliciting either electronic or written Anderson, Center for Devices and information, and to allow 60 days for
comments on all aspects of the public Radiological Health, Food and Drug public comment in response to the
workshop topics. The deadline for Administration, 10903 New Hampshire notice. This notice solicits comments on
submitting comments related to this Ave., Bldg. 66, Rm. 1552, Silver Spring, the reporting associated with
public workshop is October 6, 2016. MD 20993–0002, Sara.Anderson@ designation under the Minor Use and
Transcripts: Please be advised that as fda.hhs.gov, 301–796–6875, or FDA Minor Species Animal Health Act of
soon as a transcript is available, it will Advisory Committee Information Line, 2004.
be accessible at http:// 1–800–741–8138 (301–443–0572 in the DATES: Submit either electronic or
www.regulations.gov. It may be viewed Washington, DC area), code MA. Please written comments on the collection of
at the Division of Dockets Management call the Information Line for up-to-date information by October 21, 2016.
(see ADDRESSES). A transcript will also information on this meeting. ADDRESSES: You may submit comments
be available in either hardcopy or on SUPPLEMENTARY INFORMATION: In the as follows:
CD–ROM, after submission of a Federal Register of August 5, 2016 (81
Freedom of Information request. A Electronic Submissions
FR 51918), FDA announced that a
transcript will also be available in either meeting of the National Mammography Submit electronic comments in the
hardcopy or on CD–ROM, after Quality Assurance Advisory Committee following way:
submission of a Freedom of Information would be held on September 15, 2016. • Federal eRulemaking Portal: http://
request. The Freedom of Information On page 51919, in the first column, in www.regulations.gov. Follow the
office address is available on the the ADDRESSES portion: Hilton instructions for submitting comments.
Agency’s Web site at http:// Comments submitted electronically,
Washington, DC/North, Salons A, B, C
www.fda.gov. A link to the transcripts including attachments, to http://
and D, 620 Perry Pkwy., Gaithersburg,
will also be available approximately 45 www.regulations.gov will be posted to
MD 20877. The hotel’s telephone
days after the public workshop on the the docket unchanged. Because your
number is 301–977–8900, is changed to comment will be made public, you are
Internet at http://www.fda.gov/ read as follows: Gaithersburg Holiday
MedicalDevices/NewsEvents/ solely responsible for ensuring that your
Inn—Grand Ballroom, 2 Montgomery comment does not include any
WorkshopsConferences/default.htm. Village Ave., Gaithersburg, MD 20878.
(Select this public workshop from the confidential information that you or a
The hotel’s telephone number is 301– third party may not wish to be posted,
posted events list.) 948–8900. such as medical information, your or
Dated: August 17, 2016. This notice is issued under the anyone else’s Social Security number, or
Peter Lurie, Federal Advisory Committee Act (5 confidential business information, such
U.S.C. app. 2) and 21 CFR part 14, as a manufacturing process. Please note
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Associate Commissioner for Public Health
Strategy and Analysis. relating to the advisory committees. that if you include your name, contact
[FR Doc. 2016–19939 Filed 8–19–16; 8:45 am] Dated: August 17, 2016.
information, or other information that
BILLING CODE 4164–01–P
identifies you in the body of your
Janice M. Soreth, comments, that information will be
Acting Associate Commissioner, Special posted on http://www.regulations.gov.
Medical Programs. • If you want to submit a comment
[FR Doc. 2016–19957 Filed 8–19–16; 8:45 am] with confidential information that you
BILLING CODE 4164–01–P do not wish to be made available to the
VerDate Sep<11>2014 17:13 Aug 19, 2016 Jkt 238001 PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 E:\FR\FM\22AUN1.SGM 22AUN1](https://thefederalregister.org/doc/81_FR_56820/page/1.svg)
Document Created: 2018-02-09 11:37:48
Document Modified: 2018-02-09 11:37:48
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | S.J. Anderson, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1552, Silver Spring, MD 20993-0002, [email protected], 301-796-6875, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code MA. Please call the Information Line for up-to-date information on this meeting. | |
| FR Citation | 81 FR 56658 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR